Clinical trial

Bioequivalence Study of Atazanavir 300 mg Capsule

NCT00393328

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-11-01

PhasePHASE1

Study timeline

Study start (unknown)2006-11-01Date precision: month

Registry last updated2011-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Atazanavir + RitonavirDRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00393328 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.